West Oak Capital, LLC Astrazeneca PLC Transaction History
West Oak Capital, LLC
- $2.59 Billion
- Q1 2025
A detailed history of West Oak Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, West Oak Capital, LLC holds 175 shares of AZN stock, worth $12,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$12,615
Previous $115,000
12.17%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,393Shares Held
476MCall Options Held
6MPut Options Held
4.4M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.93 Billion2.53% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.7 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...